Sino Health
Latest round
- Series A
Last raised
- Dec 2015
Total raised
- Undisclosed
Investors
- 1
About Sino Health
Founded in 2018 in Shanghai, Sino Health has built a specialty care pharmaceutical platform targeting the Chinese market. It has expanded operations with regional offices in Beijing, Guangzhou, Chengdu, and Shenzhen. In January 2022, Nuance Biotech acquires Sino Health to further strengthen its commercial capabilities and expand pipelines. The company focuses on the in-licensing, development, and commercialization of specialty pharmaceutical products in Greater China. Therapeutic areas of focus include iron deficiency anemia, post-operative pain management, and respiratory conditions. Sino Health generates revenue through commercialization of licensed pharmaceuticals, clinical development services, and strategic partnerships in the specialty care segment. The company plans to expand its portfolio of in-licensed products, deepen commercial penetration in key therapeutic areas, and enhance its presence across the Greater China and broader Asia-Pacific markets.
Who invested in Sino Health
1 investor across 1 round
See all investors in Sino Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 4, 2015
Amount
Undisclosed
Investors
Questions about Sino Health
Who invested in Sino Health?
Sino Health has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sino Health raised?
Sino Health has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sino Health last raise money?
Sino Health's most recent round on record is a Series A, in Dec 2015.
What does Sino Health do?
Founded in 2018 in Shanghai, Sino Health has built a specialty care pharmaceutical platform targeting the Chinese market.
Where is Sino Health headquartered?
Sino Health is headquartered in Shanghai, China.
Which VCs invest in companies like Sino Health?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Sino Health's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Sino Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.